What does the evidence say about Lutein Supplementation Cognition Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Lutein Supplementation Cognition Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - Results Compared to the placebo, lutein and zeaxanthin supplementation was associated with greater improvements in visual episodic memory ( p = 0.005) and visual learning ( p = 0.001). [Lopresti AL (2022); evidence level 2] - Conclusion The results from this trial suggest that 6-months of supplementation with lutein and zeaxanthin may improve visual memory and learning in community-dwelling adults with self-reported cognitive complaints. [Lopresti AL (2022); evidence level 2] - Background Lutein and zeaxanthin are fat-soluble, dietary carotenoids with high concentrations in human brain tissue. [Lopresti AL (2022); evidence level 2] - There have been a number studies confirming an association between lutein and zeaxanthin and cognitive function. [Lopresti AL (2022); evidence level 2] - While the precise aetiology of AD remains unclear, ongoing research has yielded increasing evidence that disturbance of the biological processes associated with healthy brain ageing contribute to AD. [Ward Keanie (2025); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.